Alector has launched an $208 million stock market offering as it ramps up clinical trials with AbbVie into a drug that aims to tackle Alzheimer’s by modifying the brain’s immune system.
From AI assisted robotic surgery to clinical diagnosis, image analysis and administrative tasks, the use of artificial intelligence and machine learning (ML) technologies is increasing with
Health technology Medopad has announced a strategic collaboration with Johnson & Johnson’s pharma unit, Janssen, to research and potentially market a nationwide digital screening tool t
China’s drugs regulator has conditionally approved Shanghai Green Valley Pharmaceuticals’ Oligomannate to improve cognitive function in mild to moderate Alzheimer’s disease, the first novel
Michael Ehlers is to quit as head of Biogen’s troubled R&D outfit, taking a role as chief executive of New York-based venture capitalist Apple Tree Partners.